Sectors/🧬 Longevity & Anti-aging Biotech/NewLimit

NewLimit

NewLimit is an epigenetic reprogramming company co-founded by Coinbase CEO Brian Armstrong, focused on extending human healthspan through the restoration of youthful gene expression.

Visit Website ↗← Back to Longevity & Anti-aging Biotech

Company Details

Stage

Seed

Total Funding

$105M

Founded

2021

Headquarters

San Francisco, CA, USA

Website

newlimit.com

Sectors

🧬 Longevity & Anti-aging Biotech

Is this your company?

Claim your profile to edit details, add a logo, and see analytics.

Claim Profile

About NewLimit

NewLimit is an epigenetic reprogramming company co-founded by Coinbase CEO Brian Armstrong, focused on extending human healthspan through the restoration of youthful gene expression.